User profiles for Abdullah Algaissi
 | Abdullah AlgaissiJazan University Verified email at jazanu.edu.sa Cited by 2652 |
[HTML][HTML] Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience
AA Algaissi, NK Alharbi, M Hassanain… - Journal of infection and …, 2020 - Elsevier
Nearly four months have passed since the emergence of the severe acute respiratory
syndrome-coronavirus-2 (SARS-CoV-2), which caused the rapidly spreading Coronavirus Disease …
syndrome-coronavirus-2 (SARS-CoV-2), which caused the rapidly spreading Coronavirus Disease …
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
S Xia, L Yan, W Xu, AS Agrawal, A Algaissi… - Science …, 2019 - science.org
Continuously emerging highly pathogenic human coronaviruses (HCoVs) remain a major
threat to human health, as illustrated in past SARS-CoV and MERS-CoV outbreaks. The …
threat to human health, as illustrated in past SARS-CoV and MERS-CoV outbreaks. The …
Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
AS Agrawal, X Tao, A Algaissi, T Garron… - Human vaccines & …, 2016 - Taylor & Francis
To determine if a hypersensitive-type lung pathology might occur when mice were given an
inactivated MERS-CoV vaccine and challenged with infectious virus as was seen with SARS-…
inactivated MERS-CoV vaccine and challenged with infectious virus as was seen with SARS-…
[HTML][HTML] Evaluation of side effects associated with COVID-19 vaccines in Saudi Arabia
Background: Pfizer-BioNTech and Oxford-AstraZeneca are recently introduced vaccines to
combat COVID-19 pandemic. During clinical trials, mild to moderate side effects have been …
combat COVID-19 pandemic. During clinical trials, mild to moderate side effects have been …
[HTML][HTML] Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review
The rapidly spreading Coronavirus Disease (COVID-19) pandemic, caused by the severe
acute respiratory syndrome coronavirus (SARS-CoV-2), represents an unprecedented serious …
acute respiratory syndrome coronavirus (SARS-CoV-2), represents an unprecedented serious …
[HTML][HTML] SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients
As the Coronavirus Disease 2019 (COVID-19), which is caused by the novel SARS-CoV-2,
continues to spread rapidly around the world, there is a need for well validated serological …
continues to spread rapidly around the world, there is a need for well validated serological …
Viromimetic STING agonist‐loaded hollow polymeric nanoparticles for safe and effective vaccination against Middle East respiratory syndrome coronavirus
The continued threat of emerging, highly lethal infectious pathogens such as Middle East
respiratory syndrome coronavirus (MERS‐CoV) calls for the development of novel vaccine …
respiratory syndrome coronavirus (MERS‐CoV) calls for the development of novel vaccine …
[HTML][HTML] Bacterial coinfections increase mortality of severely ill COVID-19 patients in Saudi Arabia
Coronavirus disease 19 (COVID-19) is an ongoing global pandemic that is caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The severity and mortality rates …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The severity and mortality rates …
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces …
We developed a severe acute respiratory syndrome (SARS) subunit recombinant protein
vaccine candidate based on a high-yielding, yeast-engineered, receptor-binding domain (…
vaccine candidate based on a high-yielding, yeast-engineered, receptor-binding domain (…
[HTML][HTML] Early humoral response correlates with disease severity and outcomes in COVID-19 patients
The Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2, continues to spread
globally with significantly high morbidity and mortality rates. Antigen-specific responses are of …
globally with significantly high morbidity and mortality rates. Antigen-specific responses are of …
